Four NVIDIA Inception members have been selected as the first cohort of startups to access Cambridge-1, the U.K.’s most powerful supercomputer. The system will help British companies Alchemab Therapeutics, InstaDeep, Peptone and Relation Therapeutics enable breakthroughs in digital biology. Officially launched in July, Cambridge-1 — an NVIDIA DGX SuperPOD cluster powered by NVIDIA DGX A100 Read article >
The post First Wave of Startups Harnesses UK’s Most Powerful Supercomputer to Power Digital Biology Breakthroughs appeared first on NVIDIA Blog.
- View Press Release
- Visit NVIDIA Corporation